A detailed history of Providence Wealth Advisors, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Providence Wealth Advisors, LLC holds 76,250 shares of MCRB stock, worth $62,524. This represents 0.04% of its overall portfolio holdings.

Number of Shares
76,250
Previous 51,000 49.51%
Holding current value
$62,524
Previous $39,000 38.46%
% of portfolio
0.04%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$0.56 - $1.19 $14,140 - $30,047
25,250 Added 49.51%
76,250 $54,000
Q1 2024

May 13, 2024

BUY
$0.75 - $1.56 $38,250 - $79,560
51,000 New
51,000 $39,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $102M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Providence Wealth Advisors, LLC Portfolio

Follow Providence Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Wealth Advisors, LLC with notifications on news.